InvestorsHub Logo
Followers 5
Posts 152
Boards Moderated 0
Alias Born 06/07/2013

Re: longtermthinker post# 6953

Monday, 03/24/2014 12:10:37 PM

Monday, March 24, 2014 12:10:37 PM

Post# of 732664
Huh LTT? No tangible revenue from Germany?? They can now "charge full price", there will be "reimbursement" and "In the meantime, patients may SELF-PAY for DCVax-L."

From recent PR DATED March 10, 2014:

"Under this Hospital Exemption, NW Bio may provide DCVax-L to patients for the treatment of any glioma brain cancers (both Glioblastoma multiforme and lower grade gliomas), both newly diagnosed and recurrent, outside of the Company's clinical trial and CHARGE FULL PRICE. The patients may be from Germany or elsewhere."

"The amount and terms for such reimbursement will now be negotiated by NW Bio, the hospitals and the Sickness Funds over the coming months, and will be applied to patients case by case. In the meantime, patients may SELF-PAY for DCVax-L."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News